-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Coronavirus disease 2019 ( COVID-19 ) is caused by the severe acute respiratory syndrome coronavirus 2 infection and caused a global pandemic
.
According to reports, dyslipidemia is related to COVID-19, and these blood lipids including total cholesterol , HDL-C (high-density lipoprotein cholesterol) and LDL-C (low-density lipoprotein cholesterol) levels are significantly related to the severity of the disease
COVID-19 infection with cholesterol
Recently, the heart blood vessels published on the prestigious journal areas of Arteriosclerosis, Thrombosis, and Vascular Biology research article, the researchers conducted two sample Mendelian randomization (MR) analysis to investigate lipids and COVID 19-susceptibility and severity of Causal effect between
.
The researchers used the results data from the British Biobank (1221 cases and 4117 controls) and observed that after Bonferroni correction, dyslipidemia (odds ratio [OR] is 1.
27 [95% CI is 1.
08-1.
49], P =3.
18×10-3), total cholesterol (OR is 1.
19[95%CI is 1.
07-1.
32], P=8.
54×10−4) and ApoB (apolipoprotein B; OR is 1.
18[95%CI is 1.
07- 1.
29], P=1.
01×10−3) and potential positive causal effects between COVID-19 susceptibility
.
In addition, the researchers used the result data of the Host Genetics Initiative (14,134 cases and 1,284,876 controls) to determine total cholesterol (OR 1.
01 [95% CI 1.
00-1.
02], P=2.
29×10−2) and ApoB (OR is 1.
01[95%CI is 1.
00-1.
02], P=2.
22×10-2) and the effect of COVID-19 susceptibility
.
The results of the study indicate that higher total cholesterol and ApoB levels may increase the risk of COVID-19 infection
Original source:
Kun Zhang.
et al.
Causal Associations Between Blood Lipids and COVID-19 Risk: A Two-Sample Mendelian Randomization Study .
ATVB.
2021.